Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesStone NJ, Robinson JG, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. -
Coronary Angiography after Cardiac Arrest without ST-Segment ElevationLemkes JS, Janssens GN, van der Hoeven NW et al.
-
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS TrialsM Konigstein, PC Smits, MP Love et al.
-
Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantationGénéreux P, Giustino G, Redfors B et al.
-
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes ResearchCurry LA, Nembhard IM, Bradley EH.
-
The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probabilityKnuuti J, Ballo H, Juarez-Orozco LE et al.
-
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialDC Wheeler, BV Stefánsson, DAPA-CKD Trial Committees and Investigators et al.
-
A Novel Algorithm for Treating Chronic Total Coronary Artery OcclusionH Tanaka, E Tsuchikane, T Muramatsu et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
